(Q30451750)

15 September 2017

Oral ribavirin treatment of influenza A and B. (English)

1 reference

15 September 2017

1 reference

Stein DS

1

1 reference

15 September 2017

Creticos CM

2

1 reference

15 September 2017

Jackson GG

3

1 reference

15 September 2017

Bernstein JM

4

1 reference

15 September 2017

Hayden FG

5

1 reference

15 September 2017

Schiff GM

6

1 reference

15 September 2017

Bernstein DI

7

1 reference

15 September 2017

language of work or name

English

0 references

publication date

1 August 1987

1 reference

Antimicrobial Agents and Chemotherapy

15 September 2017

1 reference

15 September 2017

31

1 reference

15 September 2017

8

1 reference

15 September 2017

1285-1287

1 reference

Successful treatment of naturally occurring influenza A/USSR/77 H1N1.

15 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Occurrence of amantadine- and rimantadine-resistant influenza A virus strains during the 1980 epidemic

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Ribavirin small-particle aerosol treatment of influenza

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Therapeutic efficacy of amantadine HCl and rimantadine HCl in naturally occurring influenza A2 respiratory illness in man.

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Aminoadamantane-resistant strains of influenza A2 virus

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Broad-spectrum antiviral activity of Virazole: 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Lassa fever. Effective therapy with ribavirin

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Double-blind evaluation of oral ribavirin (Virazole) in experimental influenza A virus infection in volunteers

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Sensitivity of influenza A virus to amantadine

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Clinical evaluation of 1-beta-D-ribofuranosyl-1,2,4-triazole-3-carboxamide (ribavirin) in a double-blind study during an outbreak of influenza

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

Lack of effect of oral ribavirin in naturally occurring influenza A virus (H1N1) infection

20 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=174922

26 November 2018

Identifiers

DOI

10.1128/AAC.31.8.1285

1 reference

15 September 2017

1 reference

15 September 2017

PubMed publication ID

3307623

1 reference